Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/15892
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12973]
Metadata
Show full item record
PHYLODYNAMICS OF HIV-1 CIRCULATING RECOMBINANT FORMS 12_BF AND 38_BF IN ARGENTINA AND URUGUAY
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Servicio Nacional de Laboratorios de Salud Publica - MSP. Laboratorio Nacional de Referencia VIH-SIDA. Montevideo, Uruguay.
Instituto de Salud Carlos III. Centro Nacional de Microbiología. Servicio de Virologia Molecular. Madrid, Spain.
Instituto de Salud Carlos III. Centro Nacional de Microbiología. Servicio de Virologia Molecular. Madrid, Spain.
Servicio Nacional de Laboratorios de Salud Publica - MSP. Laboratorio Nacional de Referencia VIH-SIDA. Montevideo, Uruguay.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Servicio Nacional de Laboratorios de Salud Publica - MSP. Laboratorio Nacional de Referencia VIH-SIDA. Montevideo, Uruguay.
Instituto de Salud Carlos III. Centro Nacional de Microbiología. Servicio de Virologia Molecular. Madrid, Spain.
Instituto de Salud Carlos III. Centro Nacional de Microbiología. Servicio de Virologia Molecular. Madrid, Spain.
Servicio Nacional de Laboratorios de Salud Publica - MSP. Laboratorio Nacional de Referencia VIH-SIDA. Montevideo, Uruguay.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Hospital de Pediatría J P Garrahan. Laboratorio de Biología Celular y Retrovirus. CONICET. Buenos Aires, Argentina.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.
Abstract
Background: Although HIV-1 CRF12_BF and CRF38_BF are two epidemiologically important recombinant lineages
circulating in Argentina and Uruguay, little is known about their population dynamics.
Methods: A total of 120 “CRF12_BF-like” and 20 “CRF38_BF-like” pol recombinant sequences collected in Argentina
and Uruguay from 1997 to 2009 were subjected to phylogenetic and Bayesian coalescent-based analyses to
estimate evolutionary and demographic parameters.
Results: Phylogenetic analyses revealed that CRF12_BF viruses from Argentina and Uruguay constitute a single
epidemic with multiple genetic exchanges among countries; whereas circulation of the CRF38_BF seems to be
confined to Uruguay. The mean estimated substitution rate of CRF12_BF at pol gene (2.5 × 10-3 substitutions/site/
year) was similar to that previously described for subtype B. According to our estimates, CRF12_BF and CRF38_BF
originated at 1983 (1978-1988) and 1986 (1981-1990), respectively. After their emergence, the CRF12_BF and
CRF38_BF epidemics seem to have experienced a period of rapid expansion with initial growth rates of around
1.2 year-1 and 0.9 year-1, respectively. Later, the rate of spread of these CRFs_BF seems to have slowed down
since the mid-1990s.
Conclusions: Our results suggest that CRF12_BF and CRF38_BF viruses were generated during the 1980s, shortly
after the estimated introduction of subtype F1 in South America (~1975-1980). After an initial phase of fast
exponential expansion, the rate of spread of both CRFs_BF epidemics seems to have slowed down, thereby
following a demographic pattern that resembles those previously reported for the HIV-1 epidemics in Brazil, USA,
and Western Europe.
Share